Discovery, synthesis and biological evaluation of novel glucokinase activators

被引：52

作者：

McKerrecher, D ^{[1
]}

Allen, JV ^{[1
]}

Bowker, SS ^{[1
]}

Boyd, S ^{[1
]}

Caulkett, PWR ^{[1
]}

Currie, GS ^{[1
]}

Davies, CD ^{[1
]}

Fenwick, ML ^{[1
]}

Gaskin, H ^{[1
]}

Grange, E ^{[1
]}

Hargreaves, RB ^{[1
]}

Hayter, BR ^{[1
]}

James, R ^{[1
]}

Johnson, KM ^{[1
]}

Johnstone, C ^{[1
]}

Jones, CD ^{[1
]}

Lackie, S ^{[1
]}

Rayner, JW ^{[1
]}

Walker, RP ^{[1
]}

机构：

[1] AstraZeneca UK, Cardiovasc & Gastrointestinal Area, Macclesfield SK10 4TG, Cheshire, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 08期

关键词：

diabetes; glucokinase; kinase activator;

D O I：

10.1016/j.bmcl.2005.01.087

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The identification, synthesis and SAR of a novel series of glucokinase activators is described. The interplay between lipophilicity, potency and physical properties is discussed, and compound 22 highlighted as having a suitable balance. In vivo pharmacokinetic and acute efficacy studies on this compound are also presented. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：2103 / 2106

页数：4

共 50 条

[21] Design and synthesis of novel glucokinase activators as potential treatments for type 2 diabetes
McKerrecher, Darren
Allen, Joanne V.
Caulkett, Peter W. R.
Donald, Craig S.
Fenwick, Mark L.
Grange, Emma
Johnson, Keith M.
Johnstone, Craig
Jones, Cliff D.
Pike, Kurt G.
Rayner, John W.
Walker, Rolf P.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 563 - 563
[22] Discovery, Synthesis, and Biological Evaluation of Novel SMN Protein Modulators
Xiao, Jingbo
Marugan, Juan J.
Zheng, Wei
Titus, Steve
Southall, Noel
Cherry, Jonathan J.
Evans, Matthew
Androphy, Elliot J.
Austin, Christopher P.
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (18) : 6215 - 6233
[23] Synthesis of pyridone-based glucokinase activators
Filipski, Kevin J.
Jones, Christopher S.
Minich, Martha L.
Wright, Stephen W.
Li, Jian-Cheng
Guzman-Perez, Angel
Pfefferkorn, Jeffrey A.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[24] Synthetic challenges in the discovery of heterocyclic glucokinase activators for treatment of diabetes
Minich, Martha L.
Choi, Chulho
Filipski, Kevin J.
Jones, Christopher S.
Guzman-Perez, Angel
Pfefferkorn, Jeffrey A.
Risley, Hud
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
[25] Glucokinase activators
Filipski, Kevin J.
Futatsugi, Kentaro
Pfefferkorn, Jeffrey A.
Stevens, Benjamin D.
PHARMACEUTICAL PATENT ANALYST, 2012, 1 (03) : 301 - 311
[26] Glucokinase activators
不详
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (05) : 351 - 351
[27] Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators
Cheruvallath, Zacharia S.
Gwaltney, Stephen L., II
Sabat, Mark
Tang, Mingnam
Wang, Haixia
Jennings, Andy
Hosfield, David
Lee, Bumsup
Wu, Yiqin
Halkowycz, Petro
Grimshaw, Charles E.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (12) : 2678 - 2682
[28] The synthesis and biological evaluation of a range of novel functionalised benzopyrans as potential potassium channel activators
Tyrrell, Elizabeth
Tesfa, Kibur Hunie
Greenwood, Iain
Mann, Alistair
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (03) : 1237 - 1240
[29] Isoindolinones as glucokinase activators
Kester, Robert F.
Berthel, Steven J.
Guertin, Kevin R.
Tengi, John
Orzechowski, Lucja
Qi, Lida
Grimsby, Joseph
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[30] QSAR studies of novel potent benzamide derivatives as glucokinase activators
Nimisha Jain
Anand B. Mundada
Anupam K. Pathak
Medicinal Chemistry Research, 2013, 22 : 4331 - 4337

← 1 2 3 4 5 →